Analysts expect over 2020 rising revenue Novartis, quite high dividend

Tomorrow the Swiss Novartis will report its past quarters results. For this year Novartis's revenue will be around 49,83 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue of 48,62 billion CHF.

Historical revenues and results Novartis plus estimates 2020

historische koersen

The analysts expect for 2020 a net profit of 13,08 billion CHF. The majority of the analysts expects for this year a profit per share of 5,75 CHF. Based on this the price/earnings-ratio is 13,3.

Huge dividend Novartis

Per share the analysts are expecting a dividend of 3,14 CHF per share. Thus the dividend yield equals 4,11 percent. The average dividend yield of the pharmaceutical companies is a poor 0,38 percent.

Novartis's market capitalization is based on the number of outstanding shares around 176,76 billion CHF. The Novartis stock was the past 12 months quite unstable. Since last October the stock is 9 percent lower. This year the stock price moved between 65 and 96 CHF.

Historical stock prices Novartis period 2007-2020

stock graphs novartis

Click here for dividend Novartis. At 10.52 the stock trades 0,17 percent lower at 76,48 CHF.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.